ORIC position history
The shares of Oric Pharmaceuticals (ORIC) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q2: 415,926 shares, $1.9M, 0.51% of portfolio, New
- 2022 Q3: 413,526 shares, $1.3M, 0.36% of portfolio, Reduce −0.6%
- 2022 Q4: 264,237 shares, $1.6M, 0.44% of portfolio, Reduce −36.1%
- 2023 Q1: 170,326 shares, $971K, 0.29% of portfolio, Reduce −35.5%
- 2023 Q2: not held, Exit
- 2023 Q3: not held
- 2023 Q4: 72,797 shares, $670K, 0.16% of portfolio, New
- 2024 Q1: not held, Exit
- 2024 Q2: 36,000 shares, $255K, 0.06% of portfolio, New
- 2024 Q3: not held, Exit
- 2024 Q4: not held
- 2025 Q1: 242,000 shares, $1.4M, 0.38% of portfolio, New
- 2025 Q2: 135,271 shares, $1.4M, 0.38% of portfolio, Reduce −44.1%
- 2025 Q3: 104,671 shares, $1.3M, 0.31% of portfolio, Reduce −22.6%
- 2025 Q4: 141,045 shares, $1.2M, 0.27% of portfolio, Add +34.8%
- 2026 Q1: 98,724 shares, $945K, 0.22% of portfolio, Reduce −30.0%
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|